Posts by: Sreetama Dutt

Sreetama Dutt

Sreetama Dutt studied biotechnology at SRM Institute of Science and Technology, and did her Masters in medical microbiology at University of Manchester in Manchester, UK. She currently covers science and research news and also researches and writes informational resource pages for the website.

November 13, 2015November 16, 2015

Sophiris’ BPH Phase 3 Study Reports Significant and Positive Results

News

Sophiris Bio, Inc., recently announced that patients with lower urinary tract symptoms of benign prostatic hyperplasia (BPH) who were being treated with its drug candidate, PRX302 (topsalysin), showed a “statistically significant” improvement after ... Read more

September 29, 2015September 29, 2015

NeoTract’s UroLift Gets A NICE Boost For Economic And Clinical Benefits In BPH Patients

News

NeoTract Inc., a company dedicated to find innovative and clinically feasible solutions to unmet medical needs in the field of urology, received a major boost from the National Institute for Health and Care ... Read more